Full-Time
Senior Devops Engineer
I, II, III
Posted on 6/27/2024
Cellares
51-200 employees
Develops and manufactures cell therapies efficiently
Compensation Overview
$90k - $210kAnnually
Senior, Expert
San Bruno, CA, USA
- Bachelor’s degree in computer science or engineering or a technical degree with 6+ years of experience
- Solid understanding and practical experience of software development life cycles, with particular emphasis on build and release engineering functions
- Strong scripting/automation expertise (e.g. MS PowerShell)
- Strong understanding of operating systems, especially Windows and Linux preferred
- Experience with programming languages such as .Net /C# and C++ preferred
- Experience with Microsoft Visual Studio and Azure DevOps
- Understanding of PLC programming and deployment needs
- Familiar with the principles of SDLC and methodologies like Agile/Scrum, CI, Good Documentation Practices, Refactoring and Testing Techniques
- Familiarity with digital certificates (asymmetric cryptography) desired
- Experience with infrastructure as code, generation of virtualized environments with dependencies on proprietary platforms
- Experience using Ansible for infrastructure deployment and maintenance
- Familiar with automated VM management, e.g. packer, vagrant
- Hand-on experience with imaging/reimaging of Industrial PCs
- Familiarity with Docker Containers technologies and Kubernetes is a plus
- Experience in regulated industries such as medical devices, cell therapy, bioprocessing, or instrumentation is highly desirable
- Self-awareness, integrity, authenticity, and a growth/entrepreneurial mindset
- Define and implement strategies for continuous integration and release management to Cellares hardware products
- Drive the adoption of application deployment strategies
- Support and improve our tools for continuous integration, automated testing, and release management
- Act as a technologist to guide development teams through continuous integration adoption and best DevOps practices
- Create and manage pipelines for PLC and robot code generation, testing, and deployment
- Work closely with Controls and Software engineers to create end-to-end workflow automation
- Leverage modern tooling and best practices to instrument proprietary development environments and simulation tools
- Support distributed software and controls development teams and environments
- Optimize automated build systems
- Manage build communication channels and document build procedures
- Manage and maintain the version control system and all related development tools
- Ensure implementation and enforcement of defined software configuration management practices
- Define and ensure naming convention, library, and versioning consistency
Cellares develops and manufactures cell therapies in the biotechnology sector, operating as an Integrated Development and Manufacturing Organization (IDMO) that combines these processes in one facility. Its proprietary "Smart Factory" technology features an automated single-use cartridge system, which increases productivity, reduces costs, and lowers process failure rates compared to traditional methods. The company serves a range of clients, including preclinical, clinical, and commercial entities, and has partnerships with major pharmaceutical companies for CAR-T cell therapy manufacturing. Cellares aims to provide efficient and cost-effective manufacturing services, distinguishing itself from competitors in the biotechnology industry.
Company Stage
Series C
Total Funding
$373M
Headquarters
South San Francisco, California
Founded
2019
6 month growth
↑ 20%1 year growth
↑ 35%2 year growth
↑ 95%
Simplify's Take
What believers are saying
- The $380M worldwide capacity reservation and supply agreement with Bristol Myers Squibb underscores Cellares' strong market position and growth potential.
- The launch of Cell Q, the world's first automated cGMP QC workcell, demonstrates Cellares' commitment to innovation and operational efficiency.
- The addition of industry veteran Christi Shaw to the advisory board brings invaluable expertise and leadership to the company.
What critics are saying
- The complexity of integrating advanced technologies like the Cell Shuttle and Cell Q could lead to operational challenges and delays.
- The highly competitive biotechnology sector requires continuous innovation to maintain a leading position, which can be resource-intensive.
What makes Cellares unique
- Cellares is the first Integrated Development and Manufacturing Organization (IDMO), combining development and manufacturing processes under one roof, unlike traditional CDMOs.
- Their proprietary 'Smart Factory' technology, including automated single-use cartridge systems, significantly boosts productivity and reduces costs and process failure rates.
- Strategic partnerships with major pharmaceutical companies like Bristol Myers Squibb and Lyell highlight their industry credibility and advanced capabilities.